UnitedHealth Group Inc (UNH) : E&g Advisors Lp reduced its stake in UnitedHealth Group Inc by 45.23% during the most recent quarter end. The investment management company now holds a total of 12,625 shares of UnitedHealth Group Inc which is valued at $1,743,260 after selling 10,425 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Oct 11, 2016.UnitedHealth Group Inc makes up approximately 1.03% of E&g Advisors Lp’s portfolio.
Other Hedge Funds, Including , Centre Asset Management sold out all of its stake in UNH during the most recent quarter. The investment firm sold 33,890 shares of UNH which is valued $4,679,531.Advisory Services Network reduced its stake in UNH by selling 3,535 shares or 76.3% in the most recent quarter. The Hedge Fund company now holds 1,098 shares of UNH which is valued at $150,053. UnitedHealth Group Inc makes up approx 0.03% of Advisory Services Network’s portfolio.Central Bank Trust Co reduced its stake in UNH by selling 326 shares or 12.99% in the most recent quarter. The Hedge Fund company now holds 2,184 shares of UNH which is valued at $298,465. UnitedHealth Group Inc makes up approx 0.08% of Central Bank Trust Co’s portfolio.Independent Portfolio Consultants boosted its stake in UNH in the latest quarter, The investment management firm added 850 additional shares and now holds a total of 1,010 shares of UnitedHealth Group Inc which is valued at $138,976. UnitedHealth Group Inc makes up approx 0.04% of Independent Portfolio Consultants’s portfolio.Harbour Capital Advisors reduced its stake in UNH by selling 200 shares or 1.63% in the most recent quarter. The Hedge Fund company now holds 12,038 shares of UNH which is valued at $1,656,429. UnitedHealth Group Inc makes up approx 0.89% of Harbour Capital Advisors’s portfolio.
UnitedHealth Group Inc closed down -3.33 points or -2.41% at $134.75 with 33,53,588 shares getting traded on Tuesday. Post opening the session at $137.32, the shares hit an intraday low of $134.37 and an intraday high of $137.69 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.